These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 33077355)

  • 21. Therapeutic effects of hysterosalpingography contrast media in infertile women: what do we know about the H2O in the H2Oil trial and why does it matter?
    Peart JM; Sim RG; Hofman PL
    Hum Reprod; 2021 Feb; 36(3):529-535. PubMed ID: 33326555
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Oil-based versus water-based contrast for hysterosalpingography in infertile women: a systematic review and meta-analysis of randomized controlled trials.
    Fang F; Bai Y; Zhang Y; Faramand A
    Fertil Steril; 2018 Jul; 110(1):153-160.e3. PubMed ID: 29908778
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Tubal flushing for subfertility.
    Mohiyiddeen L; Hardiman A; Fitzgerald C; Hughes E; Mol BW; Johnson N; Watson A
    Cochrane Database Syst Rev; 2015 May; 2015(5):CD003718. PubMed ID: 25929235
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Oil or aqueous contrast media for hysterosalpingography: a prospective, randomized, clinical study.
    de Boer AD; Vemer HM; Willemsen WN; Sanders FB
    Eur J Obstet Gynecol Reprod Biol; 1988 May; 28(1):65-8. PubMed ID: 2839382
    [TBL] [Abstract][Full Text] [Related]  

  • 25. In vitro fertilization and multiple pregnancies: an evidence-based analysis.
    Medical Advisory Secretariat
    Ont Health Technol Assess Ser; 2006; 6(18):1-63. PubMed ID: 23074488
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Hysterosalpingography with oil contrast medium enhances fertility in patients with infertility of unknown etiology.
    Schwabe MG; Shapiro SS; Haning RV
    Fertil Steril; 1983 Nov; 40(5):604-6. PubMed ID: 6313436
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Complications after hysterosalpingography with oil- or water-based contrast: results of a nationwide survey.
    Roest I; van Welie N; Mijatovic V; Dreyer K; Bongers M; Koks C; Mol BW
    Hum Reprod Open; 2020; 2020(1):hoz045. PubMed ID: 31976383
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Potential therapeutic effects of contrast materials in hysterosalpingography: a prospective randomized clinical trial. Kaiser Permanente Infertility Work Group.
    Spring DB; Barkan HE; Pruyn SC
    Radiology; 2000 Jan; 214(1):53-7. PubMed ID: 10644101
    [TBL] [Abstract][Full Text] [Related]  

  • 29. A meta-analysis of the therapeutic role of oil soluble contrast media at hysterosalpingography: a surprising result?
    Watson A; Vandekerckhove P; Lilford R; Vail A; Brosens I; Hughes E
    Fertil Steril; 1994 Mar; 61(3):470-7. PubMed ID: 8137969
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Role of treatment with ovarian stimulation and intrauterine insemination in women with unilateral tubal occlusion diagnosed by hysterosalpingography.
    Farhi J; Ben-Haroush A; Lande Y; Fisch B
    Fertil Steril; 2007 Aug; 88(2):396-400. PubMed ID: 17445812
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Tubal flushing for subfertility.
    Johnson N; Vandekerckhove P; Watson A; Lilford R; Harada T; Hughes E
    Cochrane Database Syst Rev; 2005 Apr; (2):CD003718. PubMed ID: 15846676
    [TBL] [Abstract][Full Text] [Related]  

  • 32. A meta-analysis of fertility and adverse outcomes in oil- and water-based contrast for hysterosalpingography.
    Tsui S; Sofy AA
    Turk J Obstet Gynecol; 2023 Mar; 20(1):64-73. PubMed ID: 36908096
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Tubal flushing for subfertility.
    Johnson N; Vandekerckhove P; Watson A; Lilford R; Harada T; Hughes E
    Cochrane Database Syst Rev; 2002; (3):CD003718. PubMed ID: 12137708
    [TBL] [Abstract][Full Text] [Related]  

  • 34. WITHDRAWN: Oil-soluble versus water-soluble media for assessing tubal patency with hysterosalpingography or laparoscopy in subfertile women.
    Vandekerckhove P; Watson A; Lilford R; Harada T; Hughes E
    Cochrane Database Syst Rev; 2007 Jul; (4):CD000092. PubMed ID: 17636587
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Oil-soluble versus water-soluble media for assessing tubal patency with hysterosalpingography or laparoscopy in subfertile women.
    Vandekerckhove P; Watson A; Lilford R; Harada T; Hughes E
    Cochrane Database Syst Rev; 2000; 1996(2):CD000092. PubMed ID: 10796691
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Pregnancy rates after the use of oil-based and water-based contrast media to evaluate tubal patency.
    Letterie GS; Rose GS
    South Med J; 1990 Dec; 83(12):1402-3. PubMed ID: 2174575
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Safety of oil-based contrast medium for hysterosalpingography: a systematic review.
    Roest I; Rosielle K; van Welie N; Dreyer K; Bongers M; Mijatovic V; Mol BW; Koks C
    Reprod Biomed Online; 2021 Jun; 42(6):1119-1129. PubMed ID: 33931367
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Fertility Outcome and Safety of Ethiodized Poppy Seed Oil for Hysterosalpingography in 1,053 Infertile Patients: A Real-World Study.
    Li H; Ren Y; Yan J; Huang M; Zheng B; Luo X; Huang S; Cai S
    Front Med (Lausanne); 2022; 9():804494. PubMed ID: 35492317
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Day three versus day two embryo transfer following in vitro fertilization or intracytoplasmic sperm injection.
    Brown J; Daya S; Matson P
    Cochrane Database Syst Rev; 2016 Dec; 12(12):CD004378. PubMed ID: 27976360
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Fertility-enhancing effect of oil-based contrast agents during hysterosalpingography and the variation of this effect within a 3-year follow-up period in infertile patients.
    Lu J; Qi D; Xu W
    Front Med (Lausanne); 2022; 9():948945. PubMed ID: 36117983
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.